Adjuvant Therapy for Early Uterine High-Grade Leiomyosarcoma

Journal of Clinical Oncology - United States
doi 10.1200/jco.18.01990
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2018English

Controversies in the Adjuvant Therapy of High-Grade Gliomas

Oncologist
Cancer ResearchMedicineOncology
2011English

High Grade Uterine and Rectal Prolapse

Journal of Interdisciplinary Medicine
2016English

Cancer‑testis Antigens Are Predominantly Expressed in Uterine Leiomyosarcoma Compared With Non‑uterine Leiomyosarcoma

Oncology Letters
Cancer ResearchOncology
2017English

Biatrial High-Grade Leiomyosarcoma With Nine-Year Post-Surgical Survival

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2017English

Epithelioid Leiomyosarcoma: A Rare Uterine Cancer

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2018English

Copper Ions Are Novel Therapeutic Agents for Uterine Leiomyosarcoma

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2020English

Outcome of Adjuvant Radiotherapy After Total Hysterectomy in Patients With Uterine Leiomyosarcoma or Carcinosarcoma: A SEER-based Study

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Adjuvant Therapy for Early Endometrial Cancer — Who Benefits the Most From a Radiation Therapy?

Ginekologia Polska
GynecologyObstetrics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy